✦ LIBER ✦

534 Complement factor 5 is no genetic risk factor for the progression of liver fibrosis in chronic hepatitis C infection

✍ Scribed by J. Halangk; C. Sarrazin; G. Puhl; G. Teuber; H. Klinker; P. Buggisch; H. Hinrichsen; V. Weich; A. Bergk; B. Wiedenmann; P. Neuhaus; H. Witt; T. Berg

Book ID: 117374811
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 124 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80534-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of complement factor 5 varian

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection

✍ Juliane Halangk; Christoph Sarrazin; Konrad Neumann; Gero Puhl; Tobias Mueller; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Nuclear factor-κB in the liver of patien

Nuclear factor-κB in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression

✍ Patricia Boya; Esther Larrea; Iosu Sola; Pedro-Lorenzo Majano; Carlos Jiménez; M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

HFE C282Y gene variant is a risk factor

HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population

✍ Lukáš Pácal; Petr Husa; Vladimír Znojil; Kater̆ina Kan̆ková 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

YKL-40 genetic polymorphisms and the ris

YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C

✍ Robert J. Fontana; Heather J. Litman; Jules L. Dienstag; Herbert L. Bonkovsky; G 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB